017180.KS · 명문제약

South Korea · RS rating 41 · As of 2026-10-14

Price1,287.00 KRW
1-day change-2.2%
RS rating (overall / 1M / 3M / 12M)41 / 56 / 59 / 36
StageDeclining
Composite / Minervini / CANSLIM score19 / 12 / 21
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-54.2%
Sales growth Q/Q+6.7%
Distance from 52-week high+33.8%
Market cap (USD)$32.5M
Open South Korea in the interactive screener